InternationalUSRemember you can easily switch between MIP US and MIP International at any time

Merck wins interim relief against Teva

Simon Crompton, London

The High Court in London has granted an interim injunction against Teva to stop it launching a generic version of efavirenz, even though Teva had done nothing more than get market authorisation

Judge Birss, sitting in the High Court, granted pharmaceutical companies Merck Sharp & Dohne and Bristol-Myers Squibb (BMS) interim relief based on their argument that Teva must be planning to launch at risk because it refused to say when it...

Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain FREE access to up to five free articles when you register now.

Join here

More from the Managing IP blog

null null null

null null null

November / December 2019

IP law: are the pressures taking their toll?

Following World Mental Health Day, Max Walters seeks the views of in-house professionals on whether they struggle with workplace pressures, and asks how to improve wellbeing

Most read articles